IP Library Assignment 069084/0884
Patent Assignment
Reel/Frame 069084/0884

Assignment of Assignor's Interest

Recorded: 2024-10-31 Pages: 20
Assignor
COHERUS BIOSCIENCES, INC.
Executed: 2024-06-26
Assignee
HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
16 XUEFU ROAD, HIGH&NEW TECH DEVELOPMENT ZONE, NANJING, 210061, CHINA
Covered Properties (23)
Methods for Making Recombinant Proteins
Application: 14/845,440 →
Stable Aqueous Formulations of Adalimumab
Patent: 9,724,414 →
Application: 14/879,847 →
Publication: US 2016/0039926
Stable Aqueous Formulations of Adalimumab
Patent: 9,808,525 →
Application: 14/879,885 →
Publication: US 2016/0031982
Stable Aqueous Formulations of Adalimumab
Patent: 9,707,293 →
Application: 15/155,925 →
Publication: US 2016/0256546
Stable Aqueous Formulations of Adalimumab
Patent: 9,789,185 →
Application: 15/155,982 →
Publication: US 2016/0256547
Stable Aqueous Formulations of Adalimumab
Patent: 9,757,454 →
Application: 15/162,140 →
Publication: US 2016/0263226
Stable Aqueous Formulations of Adalimumab
Patent: 9,770,507 →
Application: 15/193,345 →
Publication: US 2016/0304599
Stable Aqueous Formulations of Adalimumab
Patent: 9,731,008 →
Application: 15/193,387 →
Publication: US 2016/0304600
Stable Aqueous Formulations of Adalimumab
Patent: 9,737,600 →
Application: 15/193,415 →
Publication: US 2016/0304601
Stable Aqueous Formulations of Adalimumab
Patent: 9,782,480 →
Application: 15/193,454 →
Publication: US 2016/0303233
Stable Aqueous Formulations of Adalimumab
Patent: 9,724,415 →
Application: 15/193,486 →
Publication: US 2016/0303234
Stable Aqueous Formulations of Adalimumab
Patent: 9,731,009 →
Application: 15/193,523 →
Publication: US 2016/0303235
High Concentration Formulations of Adalimumab
Application: 15/337,519 →
Stable Adalimumab Compositions and Methods of Their Use
Application: 15/337,845 →
Method of Filling a Container with No Headspace
Application: 15/492,999 →
Publication: US 2017/0304445
Stable Aqueous Formulations of Adalimumab
Application: 15/653,228 →
Publication: US 2017/0312361
Stable Aqueous Formulations of Adalimumab
Application: 15/677,857 →
Publication: US 2018/0021433
Stable Aqueous Formulations of Adalimumab
Application: 16/023,046 →
Publication: US 2018/0311349
Stable Aqueous Formulations of Adalimumab
Application: 16/023,152 →
Publication: US 2018/0311350
Stable Aqueous Formulations of Adalimumab
Application: 16/023,161 →
Publication: US 2018/0311351
Methods for Making Recombinant Proteins
Application: 16/564,642 →
Method of Filling a Container with No Headspace
Application: 17/350,299 →
Publication: US 2022/0040300
Method of Producing a Recombinant Protein
Application: 17/608,204 →
Publication: US 2022/0195029
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 7, 2016
From: MANNING, MARK; PAYNE, ROBERT
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 037428/0498 →
Assignment of Assignor's Interest Feb 28, 2017
From: MANNING, MARK; PAYNE, ROBERT
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 041401/0817 →
Assignment of Assignor's Interest May 1, 2018
From: MANNING, MARK; PAYNE, ROBERT W.
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 045685/0131 →
Assignment of Assignor's Interest Sep 28, 2018
From: MANNING, MARK; PAYNE, ROBERT W.
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 047007/0008 →
Assignment of Assignor's Interest Nov 8, 2018
From: MANNING, MARK; PAYNE, ROBERT W.
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 047454/0686 →
Security Interest Jan 7, 2019
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
To: HCR COLLATERAL MANAGEMENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 048021/0975 →
Assignment of Assignor's Interest Jan 21, 2020
From: MANNING, MARK; PAYNE, ROBERT W.
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 051565/0249 →
Assignment of Assignor's Interest Mar 3, 2020
From: MANNING, MARK; PAYNE, ROBERT W.
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 051996/0402 →
Assignment of Assignor's Interest Apr 22, 2020
From: LIU, JUN; MANNING, MARK; PRADO, ISAIAS
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 052467/0256 →
Assignment of Assignor's Interest Aug 4, 2020
From: OGEZ, JOHN; LIU, JUN; JI, WENCHANG; BEGLEY, PATRICK DANIEL
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 053398/0001 →
Assignment of Assignor's Interest Sep 24, 2020
From: PUCHACZ, ELZBIETA WIKTORIA
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 053875/0711 →
Assignment of Assignor's Interest Feb 5, 2021
From: MANNING, MARK; HOLCOMB, RYAN ERIK
To: COHERUS BIOSCIENCES, INC.
Reel/Frame 055165/0938 →
Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975 Jan 11, 2022
From: HCR COLLATERAL MANAGEMENT, LLC
To: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
Reel/Frame 058692/0665 →
Security Interest Mar 18, 2022
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059436/0055 →
Security Interest May 8, 2024
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.; SURFACE ONCOLOGY, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 067348/0160 →
Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 59436/0055 May 9, 2024
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
Reel/Frame 067378/0256 →